China Team Breaks Through Isotope Ac-225 Preparation Technology, Tsinghua University and PanMediso Continue to Tackle Global Supply Challenges

China Conquers Ac-225 Core Technology! Tsinghua and PanMediso Solve Global Cancer Isotope Dilemma

— A milestone breakthrough has been achieved in China’s nuclear medicine field! Tsinghua University and PanMediso announced today that their joint industry-university-research project has successfully overcome the core technology for the preparation of the new isotope Ac-225 (Actinium-225). This marks China’s achievement of self-sufficiency and control in the globally scarce α-emitting isotope sector, breaking foreign monopolies and providing a “Chinese solution” for global cancer treatment.

Isotope Ac-225: The Conflict of Soaring Demand and Supply Shortages

Ac-225, renowned as the new generation “star isotope” for its precise targeted therapy capabilities, releases α-particles with a linear energy transfer (LET) nearly a hundred times higher than that of β-emitting isotopes. Its tumor-killing effect is significantly superior to β-isotopes, and α-isotopes can directly damage the DNA double strands of tumor cells, leading to permanent cell destruction. Currently, there are over 70 development pipelines for Ac-225 radiopharmaceuticals targeting high-incidence cancers such as prostate cancer, neuroendocrine tumors, and lung cancer, but the annual supply is less than 2 curies (Ci) — only sufficient to meet the needs of about 2,000 patients, severely restricting clinical translation.

From “Bottleneck” to “Made in China”: Breaking the Preparation Technology Ice

Faced with the global challenges of Ac-225 preparation, Tsinghua University and the PanMediso team innovatively developed “accelerator-driven” preparation technology, overcoming three core bottlenecks:

  1. Efficient nuclear reaction pathway optimization: Enhancing Ac-225 yield.
  2. Efficient separation and purification processes: Achieving a purity of 99.95%, meeting pharmaceutical standards.
  3. Automated irradiation-extraction systems: Ensuring stable and controllable production.

This technology makes China one of the few countries globally capable of independent full-chain production of Ac-225, with an expected annual production capacity in the curie range, supporting over 50 clinical research projects.

Building a “Nuclear Health Protection” Ecosystem: Advancing Clinical Translation and Universal Healthcare

To accelerate technology implementation, PanMediso is simultaneously promoting industrial ecosystem construction. A clinical research alliance has been initiated, signing agreements with The Hong Kong Polytechnic University and HKSH Medical Group to conduct clinical trials surrounding Ac-225 radiopharmaceuticals.

The Raymednov health service platform has also launched, aggregating top industry experts to provide nuclear medicine education, public health consultations, and interpretations of international cutting-edge technologies. The platform aims to eliminate public misconceptions about nuclear medicine, ensuring cancer-fighting technologies benefit the populace.

A Comprehensive Innovation System: China’s Global Role in Nuclear Pharmaceuticals

Tsinghua University and PanMediso, in collaboration with The Hong Kong Polytechnic University and HKSH Medical Group, are jointly creating a “four-in-one” nuclear pharmaceutical ecosystem. This system covers the entire process from isotope preparation and radiopharmaceutical development to clinical services, driving the Chinese nuclear pharmaceutical industry from technological catch-up to global leadership.

“Ac-225 preparation is not just a technological breakthrough but a solemn commitment to life and health,” said the technical head of PanMediso. “We will continue to deepen the integration of industry, academia, and research, allowing more ‘Made in China’ radiopharmaceuticals to illuminate the path to cancer treatment.”

About PanMediso

PanMediso is one of the few leading enterprises in nuclear medicine technology platforms with a global intellectual property layout, focusing on the preparation of medical isotopes, radiopharmaceutical development, and precision diagnosis and treatment solutions, committed to enhancing human health through innovative technology.

Contact Info:
Name: Miss Li
Email: Send Email
Organization: PanMediso
Website: http://www.panmedisoholdings.com

Release ID: 89167703

In the event of any inaccuracies, problems, or queries arising from the content shared in this press release, we encourage you to notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team will be readily available to respond and take swift action within 8 hours to rectify any identified issues or assist with removal requests. Ensuring the provision of high-quality and precise information is paramount to us.

Source link

Visited 1 times, 1 visit(s) today

Related Article

The full-size, unedited version of the image of the low-observable, flying-wing aircraft. <em>via X</em>

Large Stealth Flying Wing Aircraft Photographed Over China

A recently emerged image shows a very large, low-observable, flying-wing aircraft in the air in China. While the identity of the aircraft cannot be definitively established, it matches, in many respects, the appearance of the huge drone that TWZ was first to identify in satellite imagery dating from earlier this summer, and which you can

Saving China's finless porpoise from the brink of extinction

Saving China’s finless porpoise from the brink of extinction

Stephen McDonell China correspondent Watch: Endangered porpoises at the Institute of Hydrobiology in Wuhan, China Chinese scientists are in a battle to save one of the last large animal species living in the Yangtze River – and a complete ban on fishing in the region is helping them. At the Institute of Hydrobiology in Wuhan,

After dillydallying, Thailand proceeds with Chinese-built submarine

After dillydallying, Thailand proceeds with Chinese-built submarine

CHRISTCHURCH, New Zealand — Once tempted to ditch its acquisition of a Chinese-built S26T diesel-electric submarine, Thailand has decided the project will now proceed. The cause of the indecision was China’s failure to obtain German diesel engines for the submarine, and its proposal to substitute Chinese variants instead. However, the Thai Cabinet approved a contract

Three men stand side-by-side in suits in front of a blue board

Relations between India and China thawing amid Donald Trump’s antagonism

India and China are slowly rebuilding ties with US President Donald Trump’s tariff policies playing a role in bringing the nuclear-armed rivals closer on some issues, experts say. Direct flights between the neighbouring nations are set to resume for the first time in five years, while Indian Prime Minister Narendra Modi is to meet China’s

A bird rests on a cable strung between solar panels in Hainan prefecture of western China's Qinghai province on Tuesday, July 1, 2025. (AP Photo/Ng Han Guan)

China’s carbon emissions are falling but not fast enough

TALATAN, China (AP) — High on the Tibetan plateau, Chinese government officials last month showed off what they say will be the world’s largest solar farm when completed — 610 square kilometers (235 square miles), the size of the American city of Chicago. China has been installing solar panels at a blistering pace, far faster

Source: American Soybean Association

US soybean farmers can’t afford trade war with China, warns ASA

Historically, China has been the top buyer of US soybeans by “a staggering margin,” says the American Soybean Association. This year, with US soybeans facing retaliatory tariffs amid the ongoing trade war, China is going elsewhere. In a letter urging President Trump to cut a deal with China that removes China’s retaliatory duties and includes

China develops pregnancy robot designed for full human gestation

China Develops Pregnancy Robot That Can Give Birth to Human Children

China develops a pregnancy robot designed for full human gestation. Credit: lunar caustic / CC BY 2.0 A technology company in southern China is developing a humanoid robot equipped with an artificial womb, designed to carry and give birth to human children. The project, announced by Kaiwa Technology and expected to debut by 2026, marks